Avalyn Pharma Inc.AVLN
Price (close)
$28.08
Market cap
$1.2B
P/E
—
Revenue (FY)
—
Net income
—
Dividend yield
—
1-year total return
—
Net margin
—
Revenue growth
—
Debt / equity
—
What Avalyn Pharma Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2024 | 2025 |
|---|
More on AVLN.
- Avalyn Pharma Inc. summary
- Avalyn Pharma Inc. financial statements
- Avalyn Pharma Inc. key metrics
- Avalyn Pharma Inc. health scores and style box
- Avalyn Pharma Inc. earnings
- Avalyn Pharma Inc. dividends
- Avalyn Pharma Inc. valuation
- Avalyn Pharma Inc. ownership and insiders
- Avalyn Pharma Inc. peers
Figures from Avalyn Pharma Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.